Investigational Site Number 616007

Lodz 94-074

0 studies enrolling now · 2 studies all time

What they study most

Relapsing-remitting Multiple Sclerosis, Type 2 Diabetes

Studies at this site

• Efficacy and Safety of Insulin Glargine/ Lixisenatide Fixed Ratio Combination Compared to Insulin Glargine Alone and Lixisenatide Alone on Top of Metformin in Patients With T2DM — Completed
• Efficacy and Safety of Vatelizumab in Patients With Relapsing-Remitting Multiple Sclerosis — Stopped early